WINNERS & LOSERS: Goodwin jumps; Oxford BioMedica trims revenue view
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More
| Price | 355.70p on 13-08-2026 at 08:29:35 |
|---|---|
| Change | -4.20p -1.17% |
| Buy | 355.80p |
| Sell | 355.60p |
| Last Trade: | Sell 484.00 at 355.70p |
| Day's Volume: | 515,422 |
| Last Close: | 359.90p |
| Open: | 358.00p |
| ISIN: | GB00B082RF11 |
| Day's Range | 353.50p - 358.50p |
| 52wk Range: | 329.70p - 506.80p |
| Market Capitalisation: | £8.95b |
| VWAP: | 355.47471p |
| Shares in Issue: | 2.52b |
Rentokil Initial (RTO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 484 | 355.70p | Automatic Execution |
09:27:24 - 13-Aug-26 |
| Buy* | 1,394 | 355.963p | Ordinary |
09:26:48 - 13-Aug-26 |
| Sell* | 823 | 355.824p | Negotiated Trade |
09:24:24 - 13-Aug-26 |
| Buy* | 200 | 355.80p | SI Trade |
09:23:26 - 13-Aug-26 |
| Sell* | 1,189 | 355.70p | Automatic Execution |
09:23:04 - 13-Aug-26 |
| Sell* | 621 | 355.80p | Automatic Execution |
09:23:04 - 13-Aug-26 |
| Sell* | 3,137 | 355.80p | Automatic Execution |
09:23:04 - 13-Aug-26 |
| Sell* | 1,317 | 355.80p | Automatic Execution |
09:23:04 - 13-Aug-26 |
| Buy* | 1,283 | 355.60p | Automatic Execution |
09:22:11 - 13-Aug-26 |
| Sell* | 1,094 | 355.50p | Automatic Execution |
09:22:07 - 13-Aug-26 |
Rentokil Initial (RTO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 4th Aug 2026 10:30 am | RNS | Holding(s) in Company |
| 3rd Aug 2026 1:00 pm | RNS | Director/PDMR Shareholding |
| 30th Jul 2026 7:00 am | RNS | Half-year Financial Report |
| 16th Jul 2026 10:00 am | RNS | Director Declaration |
| 21st May 2026 7:00 am | RNS | Appointment of CEO, North America |
| 8th May 2026 10:30 am | RNS | Holding(s) in Company |
| 7th May 2026 4:40 pm | RNS | Result of AGM |
| 23rd Apr 2026 4:25 pm | RNS | Final Dividend – Pence Sterling Amount Payable |
| 23rd Apr 2026 2:30 pm | RNS | Issuance of $500 million 4.625% Notes due 2031 |
| 21st Apr 2026 10:30 am | RNS | Holding(s) in Company |